Lick, Simon2008-02-062008-02-062008-02-06https://hdl.handle.net/11299/5667The information provided in this handout does not necessarily reflect the views of the University of Minnesota Medical School physicians and faculty. These materials are provided for informational purposes only and are in no way intended to take the place of the advice and recommendations of your personal health care provider. You use the information provided in these handouts at your own risk.In the outpatient setting, the evidence shows that Ribavirin as a treatment for RSV bronchiolitis in infants and children is not appropriate given the potential costs versus benefits.RSV TreatmentOutpatientRibavirinOther